Welcome to the annual meeting for Heron Therapeutics, Inc. Our host for today's call is Craig Collard. At this time, all participants will be in a listen-only mode. I will now turn the call over to your host. Mr. Collard, you may begin, sir. Good morning, ladies and gentlemen, and welcome to the Heron Therapeutics 2026 annual meeting of stockholders. My name is Craig Collard, and I serve as Chief Executive Officer and member of the Board of Directors of Heron Therapeutics. I'm joined today by Ira Duarte, Executive Vice President, Chief Financial Officer, and Melissa Jarel, Vice President of Legal. I will be presiding as chairman of this meeting. At this time, I will call the meeting to order. Melissa Jarel has been appointed to serve as our Inspector of Elections. We are pleased to hold our annual meeting virtually to increase access and participation. Stockholders may submit questions related to matters being voted on during this meeting in the space provided on the virtual shareholder meeting screen. Questions should pertain to the proposals being considered at that particular time and should be submitted before the polls close. As noted in the proxy statement previously provided to stockholders on or about April 30th, 2026, the record date for voting at this meeting was the close of business on April 14th, 2026. A list of the registered stockholders on the record date was available for the inspection by stockholders during the 10-day period prior to this meeting and will be available via the link on your virtual shareholder meeting screen. Notice of the stockholder meeting was available online and mailed out on or about April 30th, 2026 to all stockholders entitled to vote as of the record date. The transfer agent has delivered an affidavit of mailing to show that notice of this meeting was given. As of the record date, there were 188,638,866 shares of common stock outstanding and entitled to vote. In order to determine whether a quorum is present for the purpose of transacting business, does the Inspector of Elections have a preliminary report of the common stock represented at the meeting? A preliminary count of the shares of common stock represented at the meeting, virtually or by proxy, shows that the holders of more than a majority of the outstanding shares of common stock entitled to vote at the meeting is represented. In view of the report of the Inspector of Elections, I declare that a quorum is present. The meeting is now duly convened for the purposes of transacting business properly before it. If you have already submitted your proxy card, you shouldn't vote again unless you wish to revoke your proxy or change your vote. At this meeting, stockholders will be asked to vote on the six proposals described in the proxy statement. Proposal one is the election of seven director nominees to serve until the 2027 annual meeting of the stockholders and until their successors are duly elected and qualified, or until their earlier death, resignation, or removal. Proposal number two is the ratification of WithumSmith+Brown, P.C. as Heron's independent registered public accounting firm for the fiscal year ending December 31st, 2026. Proposal number three is the approval on a non-binding advisory basis of the compensation paid to Heron's named executive officers during the year ended December 31st, 2025. Proposal number four is the approval of the amendment and restatement of the company's 2007 Amended and Restated Equity Incentive Plan to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16,560,000 shares. Proposal number five is the approval of the amendment to the company's 1997 Employee Stock Purchase Plan, as amended, to increase the number of shares of common stock authorized for issuance thereunder by an additional 10 million shares. Proposal number six is the ratification on a non-binding advisory basis of the adoption of the Tax Benefits Preservation Plan. The board recommends that you vote for all seven director nominees and for proposals two through six. There are no additional matters on the agenda to be voted upon. If you have not already voted by proxy, or if you have already voted by proxy but now want to change your vote, please vote electronically at this time via the virtual shareholder meeting screen. The polls for the voting on each of these proposals are now open. We will now briefly pause to allow any final questions regarding the proposals to be submitted. We will now respond to questions related to the proposals that have been submitted. Ira, please review the questions. There are no questions for review at this time. This completes the presentation of proposals to be voted on at this meeting. Before closing the polls, we will pause for 60 seconds to allow stockholders a final opportunity to vote. Any votes cast today will be counted in the final tally, along with the proxies previously received. The polls are now officially closed. The final vote totals will be published in a current report on Form 8-K that we expect to file within four business days. Will the Inspector of Elections please report the preliminary vote count? Based on a preliminary tally of votes cast, I declare that the seven director nominees named in the proxy statement have been elected to serve until the 2027 annual meeting of stockholders and until their successors are duly elected and qualified, or until their earlier death, resignation, or removal. The appointment of WithumSmith+Brown, P.C. as Heron's independent registered public accounting firm for the fiscal year ending December 31st, 2026, has been ratified. The compensation paid to Heron's named executive officers during the year ended December 31st, 2025, has been approved on a non-binding advisory basis. The amendment and restatement of the company's 2007 Amended and Restated Equity Incentive Plan to, among other things, increase the number of shares of common stock authorized for issuance thereunder by an additional 16.56 million shares has been approved. The amendment to the company's 1997 Employee Stock Purchase Plan, as amended to increase the number of shares of common stock authorized for issuance thereunder by an additional 10 million shares has been approved, the adoption of the Tax Benefits Preservation Plan has been ratified on a non-binding advisory basis. Thank you. There being no further business, this concludes the formal portion of this meeting and the meeting is now adjourned. The meeting has now concluded. Thank you for joining, and have a pleasant day.